Cancer Proteometabolomics
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: closed (20 May 2023) | Viewed by 8615
Special Issue Editors
Interests: cancer biomarkers; proteomics; cancer surfaceome; immunooncology
Special Issues, Collections and Topics in MDPI journals
Interests: cancer biomarkers; metabolomics; metabolic vulnerabilities; therapeutics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The application of “omic” technologies coupled with advanced statistical approaches (e.g., artificial intelligence) is increasingly being utilized to reveal the molecular drivers of tumorigenesis and to derive novel treatment strategies and biomarkers that inform clinical decision making. While “omic” approaches have largely been advanced in the areas of genomics and transcriptomics, there is considerable interest and merit in exploring proteomics and metabolomics data, as these offer detailed characterization of the functional molecular machinery and the derived biochemical outputs that ultimately effect oncogenesis and shape the tumor microenvironment and tumor–host interaction. Using proteomics, metabolomics, or integrated proteomic and metabolomic approaches in the context of cancer thus has high relevance to the identification of next-generation treatment modalities that target cancer cell dependencies, as well as to biomarkers that inform upon disease status or molecular subtypes.
This Special Issue focuses on the application of proteomics, metabolomics, and integrated proteomics and metabolomics in cancer, with an emphasis on cancer biology, the tumor microenvironment and modulation of the tumor immunophenotype, biomarkers, and novel therapeutic strategies.
We are soliciting original research articles as well as reviews to contribute to this Special Issue.
Prof. Dr. Samir M. Hanash
Dr. Johannes Fahrmann
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- proteomics
- metabolomics
- cancer
- therapeutics
- biomarkers
- “omic” integration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.